The Effects Of The 32-bp CCR-5 Deletion On HIV Transmission And ...

Clipboard, Search History, and several other advanced features are temporarily unavailable. Skip to main page content Dot gov

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation pubmed logo Search: Search Advanced Clipboard User Guide Save Email Send to
  • Clipboard
  • My Bibliography
  • Collections
  • Citation manager
Display options Display options Format Abstract PubMed PMID

Save citation to file

Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel

Email citation

Email address has not been verified. Go to My NCBI account settings to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel

Add to Collections

  • Create a new collection
  • Add to an existing collection
Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error Please try again Add Cancel

Add to My Bibliography

  • My Bibliography
Unable to load your delegates due to an error Please try again Add Cancel

Your saved search

Name of saved search: Search terms: Test search terms Would you like email updates of new search results? Saved Search Alert Radio Buttons
  • Yes
  • No
Email: (change) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel

Create a file for external citation management software

Create file Cancel

Your RSS Feed

Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy

Full text links

Wiley full text link Wiley Full text links

Actions

CiteCollectionsAdd to Collections
  • Create a new collection
  • Add to an existing collection
Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an errorPlease try again Add Cancel PermalinkPermalinkCopyDisplay options Display options Format AbstractPubMedPMID

Page navigation

  • Title & authors
  • Abstract
  • Publication types
  • MeSH terms
  • Substances
  • LinkOut - more resources
Title & authors Abstract Publication types MeSH terms Substances LinkOut - more resources Full text links CiteDisplay options Display options Format AbstractPubMedPMID

Abstract

The chemokine receptor CCR5 is an important co-receptor for cell fusion. A 32-bp deletion of the CCR5 gene, leading to complete absence of functional CCR5 expression, has been associated with resistance to human immunodeficiency virus (HIV) infection in homozygotes and slower HIV disease progression in heterozygotes. The objectives of this study were to assess the effects of this 32-bp deletion on transmission of HIV infection and on HIV disease progression in haemophilic individuals. Six HIV-negative patients from our centre, known to have been exposed to infectious factor VIII concentrates, have been analysed. Three of these patients possess the CCR5 32-bp deletion, two patients being homozygous. The presence of the CCR5 32-bp gene deletion has also been analysed in 71 HIV-positive patients. In this group of patients, there was a lower than expected incidence of the 32-bp deletion. Those who possess the 32-bp deletion progress to AIDS more slowly than those who do not (P = 0.05, log-rank test). Rates of CD4 loss were slower in those heterozygous for the gene deletion. We confirm that heterozygosity for the 32-bp gene deletion in CCR5 is partially protective against initial infection with HIV. In those heterozygous patients who became infected with HIV, disease progression was slower.

PubMed Disclaimer

Publication types

  • Research Support, Non-U.S. Gov't Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search

MeSH terms

  • Acquired Immunodeficiency Syndrome / genetics Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Acquired Immunodeficiency Syndrome / immunology Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • CD4 Lymphocyte Count Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Disease Progression Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Follow-Up Studies Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Gene Deletion* Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • HIV Infections / genetics Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • HIV Infections / immunology Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • HIV Infections / transmission* Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Hemophilia A / genetics Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Hemophilia A / immunology Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Hemophilia A / virology* Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Heterozygote Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Humans Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Immunity, Innate / genetics Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Proportional Hazards Models Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • RNA, Viral / analysis Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Receptors, CCR5 / genetics* Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Survival Rate Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search

Substances

  • RNA, Viral Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search
  • Receptors, CCR5 Actions
    • Search in PubMed
    • Search in MeSH
    • Add to Search

LinkOut - more resources

  • Full Text Sources

    • Ovid Technologies, Inc.
    • Wiley
  • Medical

    • MedlinePlus Health Information
  • Research Materials

    • NCI CPTC Antibody Characterization Program
Full text links [x] Wiley full text link Wiley [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM Send To
  • Clipboard
  • Email
  • Save
  • My Bibliography
  • Collections
  • Citation Manager
[x]

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

Từ khóa » Bp X 32